Advertisement
Screener

CRONOS GROUP INC. (CRON) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

2.8 / 5 stars · 68/120 Roast Me

CRONOS GROUP INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • CRONOS GROUP INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-12-31 was 152.29K shares, a 36.18% decline year-over-year.
  • CRONOS GROUP INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-09-30 was 1.10M shares, a 10676.86% increase year-over-year.
  • CRONOS GROUP INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-06-30 was 124.13K shares, a 4.08% increase year-over-year.
  • CRONOS GROUP INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-03-31 was 1.36M shares, a 74.06% decline year-over-year.
  • CRONOS GROUP INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 2.74M shares, a 51.13% decline from fiscal 2021.
  • CRONOS GROUP INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 5.60M shares, a 162.61% increase from fiscal 2020.
  • CRONOS GROUP INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 2.13M shares, a 654.48% increase from fiscal 2019.
  • CRONOS GROUP INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2019 was 282.57K shares, a 52.70% decline from fiscal 2018.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month
2022-12-31152.29K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
2.74M shares
10-K · filed 2024-02-29
2022-09-301.10M shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
2.82M shares
derived: sum of 4 quarters · filed 2023-11-08
2022-06-30124.13K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
1.73M shares
derived: sum of 4 quarters · filed 2023-08-08
2022-03-311.36M shares
10-Q · filed 2023-05-09
1.73M shares
derived: sum of 4 quarters · filed 2023-05-09
2021-12-31238.65K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
5.60M shares
10-K · filed 2023-02-28
2021-09-3010.23K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07
5.65M shares
derived: sum of 4 quarters · filed 2022-11-07
2021-06-30119.27K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
5.67M shares
derived: sum of 4 quarters · filed 2022-08-09
2021-03-315.23M shares
10-Q · filed 2022-05-10
7.36M shares
derived: sum of 4 quarters · filed 2022-05-10
2020-12-31290.08K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
2.13M shares
10-K · filed 2022-03-01
2020-09-3033.95K shares
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-02-18
1.87M shares
derived: sum of 4 quarters · filed 2022-02-18
2020-06-301.81M shares
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2022-02-18
1.86M shares
derived: sum of 4 quarters · filed 2022-02-18
2020-03-310.00 shares
10-Q · filed 2020-05-08
156.86K shares
derived: sum of 4 quarters · filed 2021-02-26
2019-12-3128.37K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26
282.57K shares
10-K · filed 2021-02-26
2019-09-3026.86K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
2019-06-30101.63K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
2019-03-31125.72K shares
10-Q · filed 2020-05-08
2018-12-31597.38K shares
10-K/A · filed 2020-03-30
2017-12-31571.25K shares
10-K/A · filed 2020-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87